Clinical Trial Update: Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC [Phase 2]

View source ↗

Summary

This update reports a Phase 2 study evaluating stereotactic ablative radiotherapy for elderly patients with Stage I non-small cell lung cancer. The current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Luhua Wang | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN